https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-12-04 / Clin. Cancer Res. 2019 Mar;25(5):1494-1504
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-12-04 / Clin. Cancer Res. 2019 Mar;25(5):1494-15042018-12-04 00:00:002018-12-04 00:00:00Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-12-03 / Front Immunol 2018;9:2804
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-12-03 / Front Immunol 2018;9:28042018-12-03 00:00:002018-12-03 00:00:00Current State of Dendritic Cell-Based Immunotherapy: Opportunities for Antigen Loading of Different DC Subsets?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-28 / Cancers (Basel) 2018 Nov;10(12)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-28 / Cancers (Basel) 2018 Nov;10(12)2018-11-28 00:00:002019-03-27 10:44:23Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-23 / Vaccines (Basel) 2018 Nov;6(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-23 / Vaccines (Basel) 2018 Nov;6(4)2018-11-23 00:00:002018-11-23 00:00:00Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-21 / Clin Transl Oncol 2019 Jun;21(6):774-780
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-21 / Clin Transl Oncol 2019 Jun;21(6):774-7802018-11-21 00:00:002020-11-30 10:25:48Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-14 / Int J Hyperthermia 2019;36(1):9-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-14 / Int J Hyperthermia 2019;36(1):9-202018-11-14 00:00:002019-03-27 10:49:05Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-14 / Clin Transl Med 2018 Nov;7(1):35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-14 / Clin Transl Med 2018 Nov;7(1):352018-11-14 00:00:002018-11-14 00:00:00Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-12 / Cancers (Basel) 2018 Nov;10(11)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-12 / Cancers (Basel) 2018 Nov;10(11)2018-11-12 00:00:002019-02-15 08:47:42The Dilemma of Cure and Damage in Oligodendroglioma: Ways to Tip the Balance Away from the Damage
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-09 / Sci Rep 2018 Nov;8(1):16608
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-09 / Sci Rep 2018 Nov;8(1):166082018-11-09 00:00:002018-11-09 00:00:00First in vitro evidence of modulated electro-hyperthermia treatment performance in combination with megavoltage radiation by clonogenic assay
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-01 / Anticancer Res. 2018 Nov;38(11):6561-6564
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-01 / Anticancer Res. 2018 Nov;38(11):6561-65642018-11-01 00:00:002018-11-01 00:00:00Case Report of a Patient with Breast Metastasis from Gastric Cancer Treated with Paclitaxel and Ramucirumab Plus Regional Hyperthermia
